756520-73-7 Usage
General Description
1-Morpholino-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)propan-2-ol is a chemical compound that is used as a reagent in organic synthesis, particularly in the formation of carbon-carbon bonds. It contains a morpholino group, a boron-containing dioxaborolane group, and a phenoxy group, which makes it a versatile and useful molecule in the development of new drugs and materials. It is also known for its potential applications in the fields of medicinal chemistry, materials science, and chemical biology due to its unique structure and reactivity. Additionally, this compound has been studied for its potential use in the development of new pharmaceuticals and agrochemicals, as well as for its role in the synthesis of complex natural products.
Check Digit Verification of cas no
The CAS Registry Mumber 756520-73-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,5,6,5,2 and 0 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 756520-73:
(8*7)+(7*5)+(6*6)+(5*5)+(4*2)+(3*0)+(2*7)+(1*3)=177
177 % 10 = 7
So 756520-73-7 is a valid CAS Registry Number.
InChI:InChI=1/C19H30BNO5/c1-18(2)19(3,4)26-20(25-18)15-5-7-17(8-6-15)24-14-16(22)13-21-9-11-23-12-10-21/h5-8,16,22H,9-14H2,1-4H3
756520-73-7Relevant articles and documents
MAP4K4 INHIBITORS
-
Paragraph 00279, (2020/07/05)
This invention relates to compounds that may be useful as inhibitors of Mitogen-activated Protein Kinase Kinase Kinase Kinase-4 (MAP4K4). The invention also relates to the use of these compounds, for example in a method of treatmentof cardiac conditions.In particular, the present invention relates to compounds of formula (I):
AMINOHETEROARYL COMPOUNDS AS PROTEIN KINASE INHIBITORS
-
Page 113, (2010/02/08)
Aminopyridine and aminopyrazine compounds of formula (1), compositions including these compounds, and methods of their use are provided. Preferred compounds of formula 1 have activity as protein kinase inhibitors, including as inhibitors of c-MET.
